Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21184741rdf:typepubmed:Citationlld:pubmed
pubmed-article:21184741lifeskim:mentionsumls-concept:C1332002lld:lifeskim
pubmed-article:21184741lifeskim:mentionsumls-concept:C0205160lld:lifeskim
pubmed-article:21184741lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:21184741lifeskim:mentionsumls-concept:C1539270lld:lifeskim
pubmed-article:21184741lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:21184741lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:21184741lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:21184741pubmed:issue3lld:pubmed
pubmed-article:21184741pubmed:dateCreated2011-1-24lld:pubmed
pubmed-article:21184741pubmed:abstractTextHuman breast cancer resistance protein (BCRP)/MXR/ABCG2 is a well-recognized ABC half-transporter that is highly expressed at the apical membrane of many normal tissues and cancer cells. BCRP facilitates disposition of endogenous and exogenous harmful xenobiotics to protect cells/tissues from xenobiotic-induced toxicity. Despite the enormous impact of BCRP in the physiological and pathophysiological regulation of the transport of a wide variety of substrates, little is known about the factors that regulate posttranslational expression of BCRP. Here, we identified Derlin-1, a member of a family of proteins that bears homology to yeast Der1p, as a posttranslational regulator of BCRP expression. Overexpression of Derlin-1 suppressed ER to Golgi transport of wild-type (WT) BCRP that is known to be efficiently trafficked to the plasma membrane. On the other hand, protein expression of N596Q variant of BCRP, N-linked glycosylation-deficient mutant that preferentially undergoes ubiquitin-mediated ER-associated degradation (ERAD), was strongly suppressed by the overexpression of Derlin-1, whereas knockdown of Derlin-1 stabilized N596Q protein, suggesting a negative regulatory role of Derlin-1 for N596Q protein expression. Notably, knockdown of Derlin-1 also stabilized the expression of tunicamycin-induced deglycosylated WT BCRP protein, implying the importance of glycosylation state for the recognition of BCRP by Derlin-1. Thus, our data demonstrate that Derlin-1 is a negative regulator for both glycosylated and non-glycosylated BCRP expression and provide a novel posttranslational regulatory mechanism of BCRP by Derlin-1.lld:pubmed
pubmed-article:21184741pubmed:languageenglld:pubmed
pubmed-article:21184741pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21184741pubmed:citationSubsetIMlld:pubmed
pubmed-article:21184741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21184741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21184741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21184741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21184741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21184741pubmed:statusMEDLINElld:pubmed
pubmed-article:21184741pubmed:monthJanlld:pubmed
pubmed-article:21184741pubmed:issn1090-2104lld:pubmed
pubmed-article:21184741pubmed:authorpubmed-author:SatoTakashiTlld:pubmed
pubmed-article:21184741pubmed:authorpubmed-author:SugiyamaYuich...lld:pubmed
pubmed-article:21184741pubmed:authorpubmed-author:KusuharaHiroy...lld:pubmed
pubmed-article:21184741pubmed:authorpubmed-author:ShutoTsuyoshi...lld:pubmed
pubmed-article:21184741pubmed:authorpubmed-author:KaiHirofumiHlld:pubmed
pubmed-article:21184741pubmed:authorpubmed-author:CyrDouglas...lld:pubmed
pubmed-article:21184741pubmed:authorpubmed-author:SuzukiShingoSlld:pubmed
pubmed-article:21184741pubmed:authorpubmed-author:SuicoMary...lld:pubmed
pubmed-article:21184741pubmed:authorpubmed-author:SugiyamaTakas...lld:pubmed
pubmed-article:21184741pubmed:authorpubmed-author:KogaTomoakiTlld:pubmed
pubmed-article:21184741pubmed:copyrightInfoCopyright © 2010 Elsevier Inc. All rights reserved.lld:pubmed
pubmed-article:21184741pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21184741pubmed:day21lld:pubmed
pubmed-article:21184741pubmed:volume404lld:pubmed
pubmed-article:21184741pubmed:ownerNLMlld:pubmed
pubmed-article:21184741pubmed:authorsCompleteYlld:pubmed
pubmed-article:21184741pubmed:pagination853-8lld:pubmed
pubmed-article:21184741pubmed:meshHeadingpubmed-meshheading:21184741...lld:pubmed
pubmed-article:21184741pubmed:meshHeadingpubmed-meshheading:21184741...lld:pubmed
pubmed-article:21184741pubmed:meshHeadingpubmed-meshheading:21184741...lld:pubmed
pubmed-article:21184741pubmed:meshHeadingpubmed-meshheading:21184741...lld:pubmed
pubmed-article:21184741pubmed:meshHeadingpubmed-meshheading:21184741...lld:pubmed
pubmed-article:21184741pubmed:meshHeadingpubmed-meshheading:21184741...lld:pubmed
pubmed-article:21184741pubmed:meshHeadingpubmed-meshheading:21184741...lld:pubmed
pubmed-article:21184741pubmed:year2011lld:pubmed
pubmed-article:21184741pubmed:articleTitlePosttranslational negative regulation of glycosylated and non-glycosylated BCRP expression by Derlin-1.lld:pubmed
pubmed-article:21184741pubmed:affiliationDepartment of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Global COE Cell Fate Regulation Research and Education Unit, Kumamoto University, 5-1 Oe-Honmachi, Kumamoto 862-0973, Japan.lld:pubmed
pubmed-article:21184741pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21184741pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:9429entrezgene:pubmedpubmed-article:21184741lld:entrezgene
entrez-gene:79139entrezgene:pubmedpubmed-article:21184741lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21184741lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21184741lld:entrezgene